KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xylem (XYL) EBITDA Margin (2016 - 2025)

Xylem (XYL) has 15 years of EBITDA Margin data on record, last reported at 14.73% in Q4 2025.

  • For Q4 2025, EBITDA Margin rose 289.0% year-over-year to 14.73%; the TTM value through Dec 2025 reached 51.52%, up 2788.0%, while the annual FY2025 figure was 13.54%, 175.0% up from the prior year.
  • EBITDA Margin reached 14.73% in Q4 2025 per XYL's latest filing, up from 5566.67% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 14.73% in Q4 2025 and bottomed at 5566.67% in Q3 2025.
  • Average EBITDA Margin over 5 years is 1170.79%, with a median of 313.21% recorded in 2021.
  • Peak YoY movement for EBITDA Margin: skyrocketed 151898bps in 2024, then crashed -289778bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 723.81% in 2021, then surged by 102bps to 13.08% in 2022, then crashed by -11622bps to 1507.14% in 2023, then soared by 101bps to 11.84% in 2024, then rose by 24bps to 14.73% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 14.73% in Q4 2025, 5566.67% in Q3 2025, and 3388.89% in Q2 2025.